Future Clinical Trials Consulting

NCT02673255

Safety and Efficacy of Two Tetanus-Diphtheria Vaccines for a Donor Hyper Immunization Program

NCT02859857

Phase 1 Study of BXQ-350 in Adult Patients With Advanced Solid Tumors

NCT03347708

Study to Evaluate the Safety and Preliminary Efficacy of IDCT, a Treatment for Symptomatic Lumbar Intervertebral Disc Degeneration

NCT03621605

A Phase1 Study of VIB9600

NCT03608618

Intraperitoneal MCY-M11 (Mesothelin-targeting CAR) for Treatment of Advanced Ovarian Cancer and Peritoneal Mesothelioma

NCT03967093

A Study of BXQ-350 in Children and Young Adults With Relapsed Solid Tumors

NCT04036227

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GS-248

NCT04115345

A Study of a Renal Autologous Cell Therapy (REACT) in Patients With Chronic Kidney Disease (CKD) From Congenital Anomalies of the Kidney and Urinary Tract (CAKUT).

NCT04080024

A First-in-human Clinical Evaluation of SN132D in Patients With Breast and Pancreatic Cancer

NCT04137900

Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies

NCT04617509

A Study in Healthy Subjects to Evaluate Pharmacokinetics and Food Effect After Dosing of GS-248

NCT04404569

Continued Treatment for Participants Enrolled in Studies of BXQ-350

NCT04771897

A Study of BXQ-350 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) or Diffuse Midline Glioma (DMG)

NCT05016687

First-in-human Clinical Trial Evaluating CUR-N399 in Healthy Volunteers.

NCT05253105

A Clinical Study of TAB006 in Patients With Previously Treated, Advanced Malignancies

NCT05277922

Effect of C21 on Forearm Blood Flow

NCT06013163

A Phase 1 Study to Evaluate EMP22 PD and EMP16 PK Versus Xenical® in Healthy Volunteers

NCT06118684

Clinical Trial to Assess Effect of Verapamil on Systemic Exposure of EP395 and Effect of EP395 on Systemic Exposure of Midazolam and Digoxin

NCT06888362

Trial to Investigate GZ21T in Healthy Volunteers

NCT06360640

A First-in-human Trial to Evaluate Safety, Tolerability, and Pharmacokinetics of APC148 in Healthy Adults

NCT06611423

AZD3427 Effects on Renal Perfusion in Heart Failure Patients With Reduced Ejection Fraction and Renal Impairment

NCT07069725

The Phase 1, Open-label, PET Trial Designed to Investigate the Effect of AZD2389 on FAP Occupancy in the Liver in Participants With Advanced Liver Fibrosis.